Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 844 shares at $208.96 ($177K) on 2021-06-02, disclosed to the SEC on 2021-06-04.
Seasonal sale ($177k) by Director — this insider has traded VRTX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $208.96 | 285 | $60K | 33.7% |
| 2 | $208.96 | 285 | $60K | 33.7% |
| 3 | $210.01 | 153 | $32K | 18.2% |
| 4 | $211.00 | 121 | $26K | 14.4% |
| Total | $209.44 avg | 844 | $177K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |